Shares of Johnson Matthey PLC (LON:JMAT - Get Rating) have been assigned a consensus rating of "Hold" from the seven analysts that are currently covering the stock, Marketbeat Ratings reports. Six investment analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is GBX 2,173.33 ($25.70).
JMAT has been the subject of a number of analyst reports. Berenberg Bank decreased their target price on shares of Johnson Matthey from GBX 2,550 ($30.15) to GBX 2,200 ($26.01) and set a "buy" rating for the company in a research report on Tuesday, September 27th. JPMorgan Chase & Co. decreased their price objective on shares of Johnson Matthey from GBX 2,600 ($30.74) to GBX 2,150 ($25.42) and set a "neutral" rating for the company in a research report on Tuesday, October 11th. Barclays reissued an "equal weight" rating and issued a GBX 1,900 ($22.47) price objective on shares of Johnson Matthey in a research report on Wednesday, September 21st. Finally, Citigroup reissued a "neutral" rating and issued a GBX 2,200 ($26.01) price objective on shares of Johnson Matthey in a research report on Friday, August 12th.
Johnson Matthey Trading Up 0.2 %
Shares of LON:JMAT opened at GBX 2,029 ($23.99) on Tuesday. The firm has a market cap of £3.72 billion and a price-to-earnings ratio of 3,331.15. Johnson Matthey has a 12 month low of GBX 1,650 ($19.51) and a 12 month high of GBX 2,536 ($29.99). The company's fifty day simple moving average is GBX 1,943.02 and its 200 day simple moving average is GBX 2,045.31. The company has a quick ratio of 0.68, a current ratio of 1.33 and a debt-to-equity ratio of 51.33.
Insiders Place Their Bets
In other Johnson Matthey news, insider Stephen Oxley acquired 21 shares of the company's stock in a transaction on Wednesday, September 21st. The stock was acquired at an average price of GBX 1,906 ($22.54) per share, for a total transaction of £400.26 ($473.29). In other news, insider Chris Mottershead bought 166 shares of the company's stock in a transaction dated Thursday, September 29th. The stock was bought at an average cost of GBX 1,789 ($21.15) per share, for a total transaction of £2,969.74 ($3,511.58). Also, insider Stephen Oxley bought 21 shares of the company's stock in a transaction dated Wednesday, September 21st. The stock was purchased at an average price of GBX 1,906 ($22.54) per share, with a total value of £400.26 ($473.29). Insiders acquired 208 shares of company stock worth $377,047 in the last quarter.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to email@example.com.
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here